Aratana Theraptcs
(PETX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,591 | 30,164 | 9,823 | 56,786 | 68,271 |
| Marketable Securities | 71,000 | 57,249 | 88,249 | 51,470 | 2,453 |
| Receivables | 148 | 115 | 352 | 90 | 387 |
| Inventories | 882 | 645 | 427 | 203 | 124 |
| Income taxes - deferred | 158 | 158 | 158 | 1,381 | 1,381 |
| TOTAL | $85,706 | $89,380 | $99,909 | $110,544 | $73,380 |
| Non-Current Assets | |||||
| PPE Net | 1,616 | 614 | 620 | 741 | 508 |
| Investments And Advances | 0 | 2,616 | 2,452 | 1,029 | 848 |
| Intangibles | 99,497 | 98,561 | 103,721 | 108,475 | 112,692 |
| Other Non-Current Assets | 68 | 2,151 | 1,201 | 534 | 496 |
| TOTAL | $101,181 | $103,942 | $107,994 | $110,779 | $114,544 |
| Total Assets | $186,887 | $193,322 | $207,903 | $221,323 | $187,924 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 14,976 | N/A | N/A | 0 | N/A |
| Accounts payable and accrued liabilities | 1,732 | 2,136 | 1,532 | 1,888 | 991 |
| Accrued Expenses | 3,743 | 3,106 | 3,229 | 3,007 | 2,511 |
| Other current liabilities | 101 | 47 | 4,294 | 4,214 | 4,249 |
| TOTAL | $20,932 | $5,655 | $9,468 | $9,920 | $8,592 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 14,969 | 14,963 | 14,957 | 14,939 |
| Deferred Revenues | N/A | 366 | N/A | 811 | 841 |
| Other Non-Current Liabilities | 10 | 20 | 30 | 42 | 53 |
| TOTAL | $865 | $16,165 | $16,603 | $18,395 | $19,266 |
| Total Liabilities | $21,797 | $21,820 | $26,071 | $28,315 | $27,858 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,965 | 34,910 | 34,910 | 34,705 | 29,448 |
| Common Shares | 34 | 34 | 34 | 34 | 29 |
| Retained earnings | -84,721 | -76,738 | -67,964 | -55,057 | -44,927 |
| Other shareholders' equity | -8,674 | -8,158 | -4,231 | -4,036 | -816 |
| TOTAL | $165,090 | $171,502 | $181,832 | $193,008 | $160,066 |
| Total Liabilities And Equity | $186,887 | $193,322 | $207,903 | $221,323 | $187,924 |